|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5695 USD | -0.07% |
|
-17.89% | -58.52% |
| 07-15 | CbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina | CI |
| 07-14 | CbdMD Expands Oasis Beverage Distribution to South Carolina | MT |
| Market Cap | 5.98M 5.24M 4.85M 4.46M 8.41M 577M 8.55M 57.96M 22.72M 282M 22.47M 21.98M 973M | P/E 2026 * |
-3x | P/E 2027 * | -8.14x |
|---|---|---|---|---|---|
| Enterprise Value | 5.98M 5.24M 4.85M 4.46M 8.41M 577M 8.55M 57.96M 22.72M 282M 22.47M 21.98M 973M | EV / Sales 2026 * |
0.27x | EV / Sales 2027 * | 0.26x |
| Free-Float |
89.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: cbdMD, Inc.
| 1 day | -1.21% | ||
| 1 week | -17.89% | ||
| Current month | -16.79% | ||
| 1 month | -18.85% | ||
| 3 months | -30.69% | ||
| 6 months | -32.61% | ||
| Current year | -58.52% |
| 1 week | 0.55 |  | 0.7 |
| 1 month | 0.55 | | 0.82 |
| Current year | 0.55 | | 1.34 |
| 1 year | 0.47 | | 2.56 |
| 3 years | 0.47 | | 13.84 |
| 5 years | 0.47 | | 1,000.8 |
| 10 years | 0.47 | | 2,606.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
T. Kennedy
CEO | Chief Executive Officer | 47 | 01/03/2023 |
Zeb Booker
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2019 |
Sibyl Swift
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jeffrey Porter
BRD | Director/Board Member | 66 | 10/04/2025 |
T. Kennedy
BRD | Director/Board Member | 47 | 18/12/2024 |
Bakari Sellers
BRD | Director/Board Member | 41 | 01/03/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 14/04/26 | Free | Director | 1,572 | 0.0150% | ||
| 14/04/26 | Free | Director | 1,572 | 0.0150% | ||
| 14/04/26 | Free | Director | 1,572 | 0.0150% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.07% | -17.89% | -40.43% | -95.04% | 5.98M | |
| -2.73% | -1.59% | +52.60% | +150.76% | 1,051B | |
| -1.67% | -3.05% | +52.04% | +48.41% | 609B | |
| -0.41% | +2.11% | +36.99% | +78.09% | 450B | |
| -0.75% | -1.46% | +28.32% | +22.33% | 330B | |
| -1.52% | -0.95% | +33.38% | +38.39% | 284B | |
| -1.70% | -3.54% | +20.26% | +17.88% | 263B | |
| -0.58% | +1.78% | -20.89% | -38.37% | 223B | |
| -0.58% | +1.34% | +23.46% | +56.62% | 198B | |
| -0.80% | +1.69% | +23.40% | +67.14% | 167B | |
| Average | -1.00% | -1.27% | +20.91% | +34.62% | 357.51B | |
| Weighted average by Cap. | -1.15% | -0.22% | +36.83% | +72.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 22.15M 19.42M 17.95M 16.51M 31.15M 2.14B 31.65M 215M 84.13M 1.05B 83.18M 81.37M 3.6B | 23.26M 20.39M 18.85M 17.33M 32.7M 2.24B 33.23M 225M 88.34M 1.1B 87.35M 85.44M 3.78B |
| Net income | -1.9M -1.67M -1.54M -1.42M -2.67M -183M -2.72M -18.43M -7.22M -89.74M -7.14M -6.99M -309M | -902K -791K -731K -672K -1.27M -86.98M -1.29M -8.74M -3.43M -42.56M -3.39M -3.31M -147M |
| Net Debt | - | - |
Employees
42
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/07/26 | $0.5695 | -0.07% | 154,392 |
| 17/07/26 | $0.5699 | -7.63% | 231,770 |
| 16/07/26 | $0.6170 | -3.59% | 549,798 |
| 15/07/26 | $0.6400 | -2.69% | 290,841 |
| 14/07/26 | $0.6577 | -3.56% | 196,903 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.5699USD
Average target price
2.000USD
Spread / Average Target
+250.94%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- YCBD Stock
Select your edition
All financial news and data tailored to specific country editions
